Cargando…
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
Identification of regulatory mechanisms underlying the poor prognosis of ovarian cancer is necessary for diagnostic and therapeutic implications. Here we show that endothelin A receptor (ET(A)R) and ZEB1 expression is upregulated in mesenchymal ovarian cancer and correlates with poor prognosis. Nota...
Autores principales: | Sestito, Rosanna, Cianfrocca, Roberta, Tocci, Piera, Rosanò, Laura, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666224/ https://www.ncbi.nlm.nih.gov/pubmed/33188287 http://dx.doi.org/10.1038/s42003-020-01404-3 |
Ejemplares similares
-
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015) -
Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
por: Cianfrocca, Roberta, et al.
Publicado: (2016) -
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer
por: Cianfrocca, Roberta, et al.
Publicado: (2017) -
Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2022) -
Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
por: Tocci, Piera, et al.
Publicado: (2023)